Change template to: full
Chronic hematological malignancies: CM-01 – CM-05
CM-01. Comparison of prognosis between patients with therapy-related myelodysplastic syndrome after hematological malignancies and myelodysplastic syndrome de novo: retrospective cohort study
Polina V. Kotselyabina, Vladislav V. Kovalik, Vladislav V. Markelov, Nikita N. Burlov, Kirill V. Lepik, Natalia B. Mikhailova, Olga B. Kalashnikova, Nikolay Y. Tsvetkov, Ksenia S. Yurovskaya, Tatiana L. Gindina, Ivan S. Moiseev, Alexander D. Kulagin, Elena V. Morozova
CM-02. Inflammatory cytokines perturb NK cell cytotoxicity and gene signature in myeloid leukemia
Valeriya V. Kuznetsova, Amanda F. Costa, Sweta B. Patel, Francesca Luca, Victoria R. Matkins, Alana M. Franceski, Paran Goel, Robert S. Welner
CM-03. Kidney function and survival of patients with chronic lymphocytic leukemia
Maria V. Markovtseva1, Ekaterina N. Zguralskaya2
CM-04. Characteristics and treatment of blast crisis in chronic myeloid leukemia
Julia S. Yakovleva, Ksenia S. Yurovskaya, Yulia Yu. Vlasova, Ivan S. Moiseev, Elena V. Morozova
CM-05. Determining predictors of unfavorable course in low- and intermediate-risk patients with myelodysplastic syndrome
Ksenia S. Yurovskaya, Elena V. Morozova, Maria V. Barabanshchikova, Nikolay Y. Tsvetkov, Yulia Yu. Vlasova, Tatiana L. Gindina, Ildar M. Barkhatov, Ivan S. Moiseev, Alexander D. Kulagin